BAMCO Inc’s Emergent Biosolutions EBS Stock Holding History

BAMCO Inc’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-225,000	Closed	-$20.9M	–	407
2021 Q1	$20.9M	Buy	225,000 +40,000	+22%	+$4.1M	0.05%	229
2020 Q4	$16.6M	Sell	185,000 -25,000	-12%	-$2.29M	0.04%	234
2020 Q3	$21.7M	Sell	210,000 -25,000	-11%	-$2.69M	0.07%	179
2020 Q2	$18.6M	Sell	235,000 -55,000	-19%	-$4.1M	0.07%	176
2020 Q1	$16.8M	Hold	290,000	–	–	0.08%	151
2019 Q4	$15.6M	Hold	290,000	–	–	0.06%	182
2019 Q3	$15.2M	Buy	290,000 +95,000	+49%	+$4.43M	0.06%	177
2019 Q2	$9.42M	Buy	195,000 +87,000	+81%	+$4.17M	0.04%	219
2019 Q1	$5.46M	Buy	108,000 +48,000	+80%	+$2.83M	0.02%	249
2018 Q4	$3.56M	Hold	60,000	–	–	0.02%	256
2018 Q3	$3.95M	Hold	60,000	–	–	0.02%	264
2018 Q2	$3.03M	Buy	60,000 +15,000	+33%	+$782K	0.01%	262
2018 Q1	$2.37M	Hold	45,000	–	–	0.01%	261
2017 Q4	$2.09M	Buy	+45,000	New	+$1.89M	0.01%	275

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc's EBS Position: Q2 2021 in Review

BAMCO Inc sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 225,000 shares — an estimated $20.9M sold.

BAMCO Inc first reported a position in EBS in Q4 2017 and held it in 14 quarters. The position peaked at $21.7M in Q3 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

BAMCO Inc reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
BAMCO Inc sold 225,000 Emergent Biosolutions shares in Q2 2021, an estimated $20.9M.
BAMCO Inc first reported a position in Emergent Biosolutions in Q4 2017 and held it in 14 quarters.
BAMCO Inc's Emergent Biosolutions position peaked at $21.7M in Q3 2020.
290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on BAMCO Inc's 13F filing for Q2 2021, filed 13 Aug 2021.